nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP3A4—Temozolomide—melanoma	0.0955	0.385	CbGbCtD
Tramadol—CYP2D6—Vemurafenib—melanoma	0.0823	0.332	CbGbCtD
Tramadol—CYP3A4—Vemurafenib—melanoma	0.0523	0.211	CbGbCtD
Tramadol—CYP3A4—Docetaxel—melanoma	0.0179	0.0724	CbGbCtD
Tramadol—Mediastinal disorder—Temozolomide—melanoma	0.000624	0.00126	CcSEcCtD
Tramadol—Erythema—Carmustine—melanoma	0.000624	0.00126	CcSEcCtD
Tramadol—Malnutrition—Carmustine—melanoma	0.000624	0.00126	CcSEcCtD
Tramadol—Cough—Bleomycin—melanoma	0.000623	0.00126	CcSEcCtD
Tramadol—Chills—Temozolomide—melanoma	0.000621	0.00125	CcSEcCtD
Tramadol—Dehydration—Docetaxel—melanoma	0.000619	0.00125	CcSEcCtD
Tramadol—Ill-defined disorder—Dactinomycin—melanoma	0.000618	0.00125	CcSEcCtD
Tramadol—Anaemia—Dactinomycin—melanoma	0.000616	0.00124	CcSEcCtD
Tramadol—Liver function test abnormal—Docetaxel—melanoma	0.000614	0.00124	CcSEcCtD
Tramadol—Vomiting—Vemurafenib—melanoma	0.000612	0.00124	CcSEcCtD
Tramadol—Dry skin—Docetaxel—melanoma	0.00061	0.00123	CcSEcCtD
Tramadol—Chest pain—Bleomycin—melanoma	0.000608	0.00123	CcSEcCtD
Tramadol—Myalgia—Bleomycin—melanoma	0.000608	0.00123	CcSEcCtD
Tramadol—Abdominal pain upper—Docetaxel—melanoma	0.000608	0.00123	CcSEcCtD
Tramadol—Orthostatic hypotension—Docetaxel—melanoma	0.000608	0.00123	CcSEcCtD
Tramadol—Rash—Vemurafenib—melanoma	0.000607	0.00122	CcSEcCtD
Tramadol—Mental disorder—Temozolomide—melanoma	0.000607	0.00122	CcSEcCtD
Tramadol—Dermatitis—Vemurafenib—melanoma	0.000606	0.00122	CcSEcCtD
Tramadol—Back pain—Carmustine—melanoma	0.000603	0.00122	CcSEcCtD
Tramadol—Headache—Vemurafenib—melanoma	0.000603	0.00122	CcSEcCtD
Tramadol—Malnutrition—Temozolomide—melanoma	0.000603	0.00122	CcSEcCtD
Tramadol—Erythema—Temozolomide—melanoma	0.000603	0.00122	CcSEcCtD
Tramadol—Breast disorder—Docetaxel—melanoma	0.000601	0.00121	CcSEcCtD
Tramadol—Discomfort—Bleomycin—melanoma	0.000601	0.00121	CcSEcCtD
Tramadol—Malaise—Dactinomycin—melanoma	0.000601	0.00121	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000599	0.00121	CcSEcCtD
Tramadol—Cramp muscle—Docetaxel—melanoma	0.000599	0.00121	CcSEcCtD
Tramadol—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000599	0.00121	CcSEcCtD
Tramadol—Nasopharyngitis—Docetaxel—melanoma	0.000595	0.0012	CcSEcCtD
Tramadol—Dysgeusia—Temozolomide—melanoma	0.00059	0.00119	CcSEcCtD
Tramadol—Confusional state—Bleomycin—melanoma	0.000588	0.00119	CcSEcCtD
Tramadol—Venlafaxine—ABCB1—melanoma	0.000588	0.695	CrCbGaD
Tramadol—Vision blurred—Carmustine—melanoma	0.000588	0.00119	CcSEcCtD
Tramadol—Alanine aminotransferase increased—Docetaxel—melanoma	0.000587	0.00118	CcSEcCtD
Tramadol—Tremor—Carmustine—melanoma	0.000584	0.00118	CcSEcCtD
Tramadol—Anaphylactic shock—Bleomycin—melanoma	0.000583	0.00118	CcSEcCtD
Tramadol—Back pain—Temozolomide—melanoma	0.000583	0.00118	CcSEcCtD
Tramadol—Infection—Bleomycin—melanoma	0.000579	0.00117	CcSEcCtD
Tramadol—Anaemia—Carmustine—melanoma	0.000576	0.00116	CcSEcCtD
Tramadol—Dysphagia—Docetaxel—melanoma	0.000575	0.00116	CcSEcCtD
Tramadol—Agitation—Carmustine—melanoma	0.000573	0.00116	CcSEcCtD
Tramadol—Nausea—Vemurafenib—melanoma	0.000572	0.00115	CcSEcCtD
Tramadol—Thrombocytopenia—Bleomycin—melanoma	0.000571	0.00115	CcSEcCtD
Tramadol—Vision blurred—Temozolomide—melanoma	0.000568	0.00115	CcSEcCtD
Tramadol—Myalgia—Dactinomycin—melanoma	0.000567	0.00114	CcSEcCtD
Tramadol—Bronchospasm—Docetaxel—melanoma	0.000566	0.00114	CcSEcCtD
Tramadol—Tremor—Temozolomide—melanoma	0.000565	0.00114	CcSEcCtD
Tramadol—Discomfort—Dactinomycin—melanoma	0.000561	0.00113	CcSEcCtD
Tramadol—Angina pectoris—Docetaxel—melanoma	0.00056	0.00113	CcSEcCtD
Tramadol—Ill-defined disorder—Temozolomide—melanoma	0.000559	0.00113	CcSEcCtD
Tramadol—Anaemia—Temozolomide—melanoma	0.000557	0.00112	CcSEcCtD
Tramadol—Anorexia—Bleomycin—melanoma	0.000556	0.00112	CcSEcCtD
Tramadol—Agitation—Temozolomide—melanoma	0.000554	0.00112	CcSEcCtD
Tramadol—Angioedema—Temozolomide—melanoma	0.000551	0.00111	CcSEcCtD
Tramadol—Hypotension—Bleomycin—melanoma	0.000545	0.0011	CcSEcCtD
Tramadol—Malaise—Temozolomide—melanoma	0.000544	0.0011	CcSEcCtD
Tramadol—Vertigo—Temozolomide—melanoma	0.000541	0.00109	CcSEcCtD
Tramadol—Convulsion—Carmustine—melanoma	0.00054	0.00109	CcSEcCtD
Tramadol—Infection—Dactinomycin—melanoma	0.00054	0.00109	CcSEcCtD
Tramadol—Hypertension—Carmustine—melanoma	0.000538	0.00109	CcSEcCtD
Tramadol—Palpitations—Temozolomide—melanoma	0.000533	0.00107	CcSEcCtD
Tramadol—Thrombocytopenia—Dactinomycin—melanoma	0.000532	0.00107	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000531	0.00107	CcSEcCtD
Tramadol—Myalgia—Carmustine—melanoma	0.000531	0.00107	CcSEcCtD
Tramadol—Chest pain—Carmustine—melanoma	0.000531	0.00107	CcSEcCtD
Tramadol—Anxiety—Carmustine—melanoma	0.000529	0.00107	CcSEcCtD
Tramadol—Cough—Temozolomide—melanoma	0.000526	0.00106	CcSEcCtD
Tramadol—Paraesthesia—Bleomycin—melanoma	0.000524	0.00106	CcSEcCtD
Tramadol—Convulsion—Temozolomide—melanoma	0.000522	0.00105	CcSEcCtD
Tramadol—Weight decreased—Docetaxel—melanoma	0.00052	0.00105	CcSEcCtD
Tramadol—Hypertension—Temozolomide—melanoma	0.00052	0.00105	CcSEcCtD
Tramadol—Dyspnoea—Bleomycin—melanoma	0.00052	0.00105	CcSEcCtD
Tramadol—Anorexia—Dactinomycin—melanoma	0.000518	0.00105	CcSEcCtD
Tramadol—Pneumonia—Docetaxel—melanoma	0.000516	0.00104	CcSEcCtD
Tramadol—Confusional state—Carmustine—melanoma	0.000513	0.00104	CcSEcCtD
Tramadol—Arthralgia—Temozolomide—melanoma	0.000513	0.00104	CcSEcCtD
Tramadol—Myalgia—Temozolomide—melanoma	0.000513	0.00104	CcSEcCtD
Tramadol—Infestation NOS—Docetaxel—melanoma	0.000513	0.00104	CcSEcCtD
Tramadol—Infestation—Docetaxel—melanoma	0.000513	0.00104	CcSEcCtD
Tramadol—Anxiety—Temozolomide—melanoma	0.000511	0.00103	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00051	0.00103	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000508	0.00103	CcSEcCtD
Tramadol—Discomfort—Temozolomide—melanoma	0.000507	0.00102	CcSEcCtD
Tramadol—Decreased appetite—Bleomycin—melanoma	0.000507	0.00102	CcSEcCtD
Tramadol—Infection—Carmustine—melanoma	0.000506	0.00102	CcSEcCtD
Tramadol—Acute coronary syndrome—Docetaxel—melanoma	0.000506	0.00102	CcSEcCtD
Tramadol—Renal failure—Docetaxel—melanoma	0.000504	0.00102	CcSEcCtD
Tramadol—Myocardial infarction—Docetaxel—melanoma	0.000503	0.00101	CcSEcCtD
Tramadol—Dry mouth—Temozolomide—melanoma	0.000502	0.00101	CcSEcCtD
Tramadol—Stomatitis—Docetaxel—melanoma	0.0005	0.00101	CcSEcCtD
Tramadol—Pain—Bleomycin—melanoma	0.000499	0.00101	CcSEcCtD
Tramadol—Conjunctivitis—Docetaxel—melanoma	0.000499	0.00101	CcSEcCtD
Tramadol—Thrombocytopenia—Carmustine—melanoma	0.000498	0.00101	CcSEcCtD
Tramadol—Tachycardia—Carmustine—melanoma	0.000497	0.001	CcSEcCtD
Tramadol—Confusional state—Temozolomide—melanoma	0.000496	0.001	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000495	0.001	CcSEcCtD
Tramadol—Anaphylactic shock—Temozolomide—melanoma	0.000492	0.000993	CcSEcCtD
Tramadol—Infection—Temozolomide—melanoma	0.000489	0.000986	CcSEcCtD
Tramadol—Anorexia—Carmustine—melanoma	0.000485	0.000979	CcSEcCtD
Tramadol—Hepatobiliary disease—Docetaxel—melanoma	0.000485	0.000979	CcSEcCtD
Tramadol—Epistaxis—Docetaxel—melanoma	0.000484	0.000976	CcSEcCtD
Tramadol—Nervous system disorder—Temozolomide—melanoma	0.000482	0.000974	CcSEcCtD
Tramadol—Thrombocytopenia—Temozolomide—melanoma	0.000482	0.000972	CcSEcCtD
Tramadol—Feeling abnormal—Bleomycin—melanoma	0.000481	0.00097	CcSEcCtD
Tramadol—Skin disorder—Temozolomide—melanoma	0.000478	0.000964	CcSEcCtD
Tramadol—Hypotension—Carmustine—melanoma	0.000476	0.00096	CcSEcCtD
Tramadol—Hyperhidrosis—Temozolomide—melanoma	0.000476	0.00096	CcSEcCtD
Tramadol—Decreased appetite—Dactinomycin—melanoma	0.000473	0.000954	CcSEcCtD
Tramadol—Fatigue—Dactinomycin—melanoma	0.000469	0.000946	CcSEcCtD
Tramadol—Anorexia—Temozolomide—melanoma	0.000469	0.000946	CcSEcCtD
Tramadol—Pain—Dactinomycin—melanoma	0.000465	0.000939	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Carmustine—melanoma	0.000464	0.000936	CcSEcCtD
Tramadol—Urticaria—Bleomycin—melanoma	0.000463	0.000935	CcSEcCtD
Tramadol—Haemoglobin—Docetaxel—melanoma	0.000463	0.000934	CcSEcCtD
Tramadol—Rhinitis—Docetaxel—melanoma	0.000462	0.000932	CcSEcCtD
Tramadol—Body temperature increased—Bleomycin—melanoma	0.000461	0.00093	CcSEcCtD
Tramadol—Haemorrhage—Docetaxel—melanoma	0.00046	0.000929	CcSEcCtD
Tramadol—Hepatitis—Docetaxel—melanoma	0.00046	0.000929	CcSEcCtD
Tramadol—Insomnia—Carmustine—melanoma	0.00046	0.000929	CcSEcCtD
Tramadol—Hypoaesthesia—Docetaxel—melanoma	0.000458	0.000925	CcSEcCtD
Tramadol—Paraesthesia—Carmustine—melanoma	0.000457	0.000922	CcSEcCtD
Tramadol—Pharyngitis—Docetaxel—melanoma	0.000457	0.000922	CcSEcCtD
Tramadol—Urinary tract disorder—Docetaxel—melanoma	0.000455	0.000918	CcSEcCtD
Tramadol—Dyspnoea—Carmustine—melanoma	0.000454	0.000916	CcSEcCtD
Tramadol—Oedema peripheral—Docetaxel—melanoma	0.000454	0.000915	CcSEcCtD
Tramadol—Somnolence—Carmustine—melanoma	0.000453	0.000913	CcSEcCtD
Tramadol—Connective tissue disorder—Docetaxel—melanoma	0.000452	0.000913	CcSEcCtD
Tramadol—Urethral disorder—Docetaxel—melanoma	0.000451	0.000911	CcSEcCtD
Tramadol—Feeling abnormal—Dactinomycin—melanoma	0.000448	0.000904	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Temozolomide—melanoma	0.000448	0.000904	CcSEcCtD
Tramadol—Insomnia—Temozolomide—melanoma	0.000445	0.000898	CcSEcCtD
Tramadol—Gastrointestinal pain—Dactinomycin—melanoma	0.000445	0.000897	CcSEcCtD
Tramadol—Visual impairment—Docetaxel—melanoma	0.000444	0.000895	CcSEcCtD
Tramadol—Decreased appetite—Carmustine—melanoma	0.000442	0.000893	CcSEcCtD
Tramadol—Paraesthesia—Temozolomide—melanoma	0.000442	0.000891	CcSEcCtD
Tramadol—Gastrointestinal disorder—Carmustine—melanoma	0.000439	0.000887	CcSEcCtD
Tramadol—Dyspnoea—Temozolomide—melanoma	0.000439	0.000885	CcSEcCtD
Tramadol—Somnolence—Temozolomide—melanoma	0.000437	0.000883	CcSEcCtD
Tramadol—Erythema multiforme—Docetaxel—melanoma	0.000435	0.000879	CcSEcCtD
Tramadol—Pain—Carmustine—melanoma	0.000435	0.000878	CcSEcCtD
Tramadol—Constipation—Carmustine—melanoma	0.000435	0.000878	CcSEcCtD
Tramadol—Dyspepsia—Temozolomide—melanoma	0.000433	0.000874	CcSEcCtD
Tramadol—Eye disorder—Docetaxel—melanoma	0.00043	0.000868	CcSEcCtD
Tramadol—Abdominal pain—Dactinomycin—melanoma	0.00043	0.000868	CcSEcCtD
Tramadol—Body temperature increased—Dactinomycin—melanoma	0.00043	0.000868	CcSEcCtD
Tramadol—Hypersensitivity—Bleomycin—melanoma	0.00043	0.000867	CcSEcCtD
Tramadol—Decreased appetite—Temozolomide—melanoma	0.000428	0.000863	CcSEcCtD
Tramadol—Cardiac disorder—Docetaxel—melanoma	0.000427	0.000862	CcSEcCtD
Tramadol—Flushing—Docetaxel—melanoma	0.000427	0.000862	CcSEcCtD
Tramadol—Gastrointestinal disorder—Temozolomide—melanoma	0.000425	0.000857	CcSEcCtD
Tramadol—Fatigue—Temozolomide—melanoma	0.000424	0.000856	CcSEcCtD
Tramadol—Pain—Temozolomide—melanoma	0.000421	0.000849	CcSEcCtD
Tramadol—Constipation—Temozolomide—melanoma	0.000421	0.000849	CcSEcCtD
Tramadol—Feeling abnormal—Carmustine—melanoma	0.000419	0.000847	CcSEcCtD
Tramadol—Asthenia—Bleomycin—melanoma	0.000418	0.000844	CcSEcCtD
Tramadol—Angiopathy—Docetaxel—melanoma	0.000418	0.000843	CcSEcCtD
Tramadol—Gastrointestinal pain—Carmustine—melanoma	0.000416	0.00084	CcSEcCtD
Tramadol—Immune system disorder—Docetaxel—melanoma	0.000416	0.000839	CcSEcCtD
Tramadol—Mediastinal disorder—Docetaxel—melanoma	0.000415	0.000837	CcSEcCtD
Tramadol—Chills—Docetaxel—melanoma	0.000413	0.000834	CcSEcCtD
Tramadol—Pruritus—Bleomycin—melanoma	0.000413	0.000833	CcSEcCtD
Tramadol—Arrhythmia—Docetaxel—melanoma	0.000411	0.00083	CcSEcCtD
Tramadol—Feeling abnormal—Temozolomide—melanoma	0.000405	0.000818	CcSEcCtD
Tramadol—Mental disorder—Docetaxel—melanoma	0.000403	0.000814	CcSEcCtD
Tramadol—Body temperature increased—Carmustine—melanoma	0.000402	0.000812	CcSEcCtD
Tramadol—Abdominal pain—Carmustine—melanoma	0.000402	0.000812	CcSEcCtD
Tramadol—Gastrointestinal pain—Temozolomide—melanoma	0.000402	0.000812	CcSEcCtD
Tramadol—Erythema—Docetaxel—melanoma	0.000401	0.000809	CcSEcCtD
Tramadol—Malnutrition—Docetaxel—melanoma	0.000401	0.000809	CcSEcCtD
Tramadol—Hypersensitivity—Dactinomycin—melanoma	0.000401	0.000809	CcSEcCtD
Tramadol—Dysgeusia—Docetaxel—melanoma	0.000392	0.000792	CcSEcCtD
Tramadol—Urticaria—Temozolomide—melanoma	0.000391	0.000789	CcSEcCtD
Tramadol—Asthenia—Dactinomycin—melanoma	0.00039	0.000787	CcSEcCtD
Tramadol—Body temperature increased—Temozolomide—melanoma	0.000389	0.000785	CcSEcCtD
Tramadol—Abdominal pain—Temozolomide—melanoma	0.000389	0.000785	CcSEcCtD
Tramadol—Back pain—Docetaxel—melanoma	0.000388	0.000782	CcSEcCtD
Tramadol—Muscle spasms—Docetaxel—melanoma	0.000385	0.000778	CcSEcCtD
Tramadol—Hypersensitivity—Carmustine—melanoma	0.000375	0.000757	CcSEcCtD
Tramadol—Diarrhoea—Dactinomycin—melanoma	0.000372	0.000751	CcSEcCtD
Tramadol—Vomiting—Bleomycin—melanoma	0.000371	0.000748	CcSEcCtD
Tramadol—Anaemia—Docetaxel—melanoma	0.00037	0.000748	CcSEcCtD
Tramadol—Rash—Bleomycin—melanoma	0.000368	0.000742	CcSEcCtD
Tramadol—Dermatitis—Bleomycin—melanoma	0.000367	0.000741	CcSEcCtD
Tramadol—Asthenia—Carmustine—melanoma	0.000365	0.000737	CcSEcCtD
Tramadol—Hypersensitivity—Temozolomide—melanoma	0.000362	0.000731	CcSEcCtD
Tramadol—Syncope—Docetaxel—melanoma	0.000359	0.000725	CcSEcCtD
Tramadol—Palpitations—Docetaxel—melanoma	0.000354	0.000715	CcSEcCtD
Tramadol—Asthenia—Temozolomide—melanoma	0.000353	0.000712	CcSEcCtD
Tramadol—Loss of consciousness—Docetaxel—melanoma	0.000352	0.000711	CcSEcCtD
Tramadol—Cough—Docetaxel—melanoma	0.00035	0.000706	CcSEcCtD
Tramadol—Diarrhoea—Carmustine—melanoma	0.000348	0.000703	CcSEcCtD
Tramadol—Pruritus—Temozolomide—melanoma	0.000348	0.000702	CcSEcCtD
Tramadol—Convulsion—Docetaxel—melanoma	0.000347	0.000701	CcSEcCtD
Tramadol—Nausea—Bleomycin—melanoma	0.000346	0.000699	CcSEcCtD
Tramadol—Hypertension—Docetaxel—melanoma	0.000346	0.000698	CcSEcCtD
Tramadol—Vomiting—Dactinomycin—melanoma	0.000346	0.000698	CcSEcCtD
Tramadol—Rash—Dactinomycin—melanoma	0.000343	0.000692	CcSEcCtD
Tramadol—Myalgia—Docetaxel—melanoma	0.000341	0.000689	CcSEcCtD
Tramadol—Arthralgia—Docetaxel—melanoma	0.000341	0.000689	CcSEcCtD
Tramadol—Chest pain—Docetaxel—melanoma	0.000341	0.000689	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000339	0.000684	CcSEcCtD
Tramadol—Dizziness—Carmustine—melanoma	0.000337	0.000679	CcSEcCtD
Tramadol—Diarrhoea—Temozolomide—melanoma	0.000337	0.000679	CcSEcCtD
Tramadol—Dry mouth—Docetaxel—melanoma	0.000334	0.000674	CcSEcCtD
Tramadol—Confusional state—Docetaxel—melanoma	0.00033	0.000666	CcSEcCtD
Tramadol—Anaphylactic shock—Docetaxel—melanoma	0.000327	0.00066	CcSEcCtD
Tramadol—Dizziness—Temozolomide—melanoma	0.000325	0.000656	CcSEcCtD
Tramadol—Infection—Docetaxel—melanoma	0.000325	0.000656	CcSEcCtD
Tramadol—Vomiting—Carmustine—melanoma	0.000324	0.000653	CcSEcCtD
Tramadol—Nausea—Dactinomycin—melanoma	0.000323	0.000652	CcSEcCtD
Tramadol—Shock—Docetaxel—melanoma	0.000322	0.000649	CcSEcCtD
Tramadol—Rash—Carmustine—melanoma	0.000321	0.000648	CcSEcCtD
Tramadol—Nervous system disorder—Docetaxel—melanoma	0.000321	0.000647	CcSEcCtD
Tramadol—Dermatitis—Carmustine—melanoma	0.000321	0.000647	CcSEcCtD
Tramadol—Thrombocytopenia—Docetaxel—melanoma	0.00032	0.000646	CcSEcCtD
Tramadol—Tachycardia—Docetaxel—melanoma	0.000319	0.000644	CcSEcCtD
Tramadol—Headache—Carmustine—melanoma	0.000319	0.000644	CcSEcCtD
Tramadol—Skin disorder—Docetaxel—melanoma	0.000318	0.000641	CcSEcCtD
Tramadol—Vomiting—Temozolomide—melanoma	0.000313	0.000631	CcSEcCtD
Tramadol—Anorexia—Docetaxel—melanoma	0.000312	0.000629	CcSEcCtD
Tramadol—Rash—Temozolomide—melanoma	0.00031	0.000626	CcSEcCtD
Tramadol—Dermatitis—Temozolomide—melanoma	0.00031	0.000625	CcSEcCtD
Tramadol—Headache—Temozolomide—melanoma	0.000308	0.000622	CcSEcCtD
Tramadol—Hypotension—Docetaxel—melanoma	0.000306	0.000617	CcSEcCtD
Tramadol—Nausea—Carmustine—melanoma	0.000302	0.00061	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000298	0.000601	CcSEcCtD
Tramadol—Insomnia—Docetaxel—melanoma	0.000296	0.000597	CcSEcCtD
Tramadol—Paraesthesia—Docetaxel—melanoma	0.000294	0.000593	CcSEcCtD
Tramadol—Nausea—Temozolomide—melanoma	0.000292	0.00059	CcSEcCtD
Tramadol—Dyspnoea—Docetaxel—melanoma	0.000292	0.000589	CcSEcCtD
Tramadol—Somnolence—Docetaxel—melanoma	0.000291	0.000587	CcSEcCtD
Tramadol—Dyspepsia—Docetaxel—melanoma	0.000288	0.000581	CcSEcCtD
Tramadol—Decreased appetite—Docetaxel—melanoma	0.000284	0.000574	CcSEcCtD
Tramadol—Gastrointestinal disorder—Docetaxel—melanoma	0.000282	0.00057	CcSEcCtD
Tramadol—Fatigue—Docetaxel—melanoma	0.000282	0.000569	CcSEcCtD
Tramadol—Pain—Docetaxel—melanoma	0.00028	0.000565	CcSEcCtD
Tramadol—Constipation—Docetaxel—melanoma	0.00028	0.000565	CcSEcCtD
Tramadol—Feeling abnormal—Docetaxel—melanoma	0.00027	0.000544	CcSEcCtD
Tramadol—Gastrointestinal pain—Docetaxel—melanoma	0.000267	0.00054	CcSEcCtD
Tramadol—Abdominal pain—Docetaxel—melanoma	0.000259	0.000522	CcSEcCtD
Tramadol—Body temperature increased—Docetaxel—melanoma	0.000259	0.000522	CcSEcCtD
Tramadol—Dextromethorphan—ABCB1—melanoma	0.000257	0.305	CrCbGaD
Tramadol—Hypersensitivity—Docetaxel—melanoma	0.000241	0.000486	CcSEcCtD
Tramadol—Asthenia—Docetaxel—melanoma	0.000235	0.000474	CcSEcCtD
Tramadol—Pruritus—Docetaxel—melanoma	0.000231	0.000467	CcSEcCtD
Tramadol—Diarrhoea—Docetaxel—melanoma	0.000224	0.000452	CcSEcCtD
Tramadol—Dizziness—Docetaxel—melanoma	0.000216	0.000437	CcSEcCtD
Tramadol—Vomiting—Docetaxel—melanoma	0.000208	0.00042	CcSEcCtD
Tramadol—Rash—Docetaxel—melanoma	0.000206	0.000416	CcSEcCtD
Tramadol—Dermatitis—Docetaxel—melanoma	0.000206	0.000416	CcSEcCtD
Tramadol—Headache—Docetaxel—melanoma	0.000205	0.000414	CcSEcCtD
Tramadol—Nausea—Docetaxel—melanoma	0.000194	0.000392	CcSEcCtD
Tramadol—HTR2C—Signaling Pathways—KDR—melanoma	2.24e-05	8.77e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MDM2—melanoma	2.24e-05	8.76e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GNAQ—melanoma	2.23e-05	8.74e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CD44—melanoma	2.23e-05	8.74e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCND1—melanoma	2.23e-05	8.7e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SPP1—melanoma	2.23e-05	8.7e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAP2K2—melanoma	2.22e-05	8.68e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL8—melanoma	2.22e-05	8.67e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ERBB2—melanoma	2.21e-05	8.64e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CTNNB1—melanoma	2.2e-05	8.62e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF1—melanoma	2.2e-05	8.61e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PLA2G6—melanoma	2.2e-05	8.58e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—MAPK1—melanoma	2.19e-05	8.57e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—melanoma	2.19e-05	8.57e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CB—melanoma	2.18e-05	8.53e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—melanoma	2.16e-05	8.45e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FN1—melanoma	2.16e-05	8.44e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CDKN1A—melanoma	2.15e-05	8.42e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTEN—melanoma	2.15e-05	8.4e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1B1—melanoma	2.14e-05	8.38e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NFKB1—melanoma	2.14e-05	8.36e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAP2K1—melanoma	2.13e-05	8.32e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CG—melanoma	2.13e-05	8.31e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2—melanoma	2.12e-05	8.28e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CD—melanoma	2.11e-05	8.27e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOTCH1—melanoma	2.11e-05	8.26e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TERT—melanoma	2.11e-05	8.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAC1—melanoma	2.1e-05	8.23e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—melanoma	2.1e-05	8.2e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL8—melanoma	2.1e-05	8.19e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	2.09e-05	8.19e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HRAS—melanoma	2.08e-05	8.14e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KRAS—melanoma	2.07e-05	8.09e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CD80—melanoma	2.07e-05	8.09e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APC—melanoma	2.07e-05	8.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CG—melanoma	2.07e-05	8.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KIT—melanoma	2.07e-05	8.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—NRAS—melanoma	2.07e-05	8.08e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARG—melanoma	2.05e-05	8.02e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1B—melanoma	2.05e-05	8e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGF—melanoma	2.04e-05	7.98e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FGF2—melanoma	2.02e-05	7.92e-05	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—melanoma	2.02e-05	7.91e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIF1A—melanoma	2.02e-05	7.89e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—melanoma	2.01e-05	7.84e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—melanoma	2e-05	7.83e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—melanoma	1.99e-05	7.79e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—MAPK3—melanoma	1.98e-05	7.73e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—VCAN—melanoma	1.97e-05	7.71e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—melanoma	1.95e-05	7.63e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BRAF—melanoma	1.94e-05	7.59e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—melanoma	1.94e-05	7.59e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CTNNB1—melanoma	1.93e-05	7.56e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KDR—melanoma	1.93e-05	7.55e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—melanoma	1.92e-05	7.51e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NRAS—melanoma	1.92e-05	7.5e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CA—melanoma	1.9e-05	7.44e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—melanoma	1.9e-05	7.41e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MDM2—melanoma	1.89e-05	7.41e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1—melanoma	1.89e-05	7.39e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1A—melanoma	1.89e-05	7.38e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTEN—melanoma	1.88e-05	7.37e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—MAPK1—melanoma	1.88e-05	7.36e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—melanoma	1.88e-05	7.36e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NFKB1—melanoma	1.88e-05	7.33e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CD—melanoma	1.87e-05	7.31e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB2—melanoma	1.87e-05	7.3e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FN1—melanoma	1.86e-05	7.26e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—melanoma	1.85e-05	7.22e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CB—melanoma	1.84e-05	7.21e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—melanoma	1.84e-05	7.19e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK3—melanoma	1.84e-05	7.18e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CG—melanoma	1.83e-05	7.15e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAP2K1—melanoma	1.83e-05	7.15e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH1—melanoma	1.82e-05	7.11e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CD—melanoma	1.82e-05	7.1e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CA—melanoma	1.8e-05	7.03e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—melanoma	1.79e-05	6.98e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CD80—melanoma	1.78e-05	6.97e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KIT—melanoma	1.78e-05	6.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CG—melanoma	1.78e-05	6.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APC—melanoma	1.78e-05	6.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—NRAS—melanoma	1.78e-05	6.95e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—melanoma	1.78e-05	6.95e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—melanoma	1.77e-05	6.92e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARG—melanoma	1.77e-05	6.9e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCB1—melanoma	1.76e-05	6.9e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HRAS—melanoma	1.76e-05	6.88e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGF—melanoma	1.76e-05	6.87e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK1—melanoma	1.75e-05	6.83e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—melanoma	1.75e-05	6.83e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGF2—melanoma	1.74e-05	6.8e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1B—melanoma	1.73e-05	6.76e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—melanoma	1.71e-05	6.69e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—MAPK3—melanoma	1.7e-05	6.66e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—melanoma	1.7e-05	6.65e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—melanoma	1.69e-05	6.63e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—melanoma	1.69e-05	6.62e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—melanoma	1.69e-05	6.59e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—melanoma	1.68e-05	6.58e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NRAS—melanoma	1.68e-05	6.57e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BRAF—melanoma	1.67e-05	6.54e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP17A1—melanoma	1.66e-05	6.51e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—melanoma	1.65e-05	6.45e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—melanoma	1.65e-05	6.45e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CTNNB1—melanoma	1.63e-05	6.39e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CA—melanoma	1.63e-05	6.39e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CB—melanoma	1.63e-05	6.37e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1—melanoma	1.63e-05	6.37e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MDM2—melanoma	1.63e-05	6.36e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PRKCA—melanoma	1.62e-05	6.35e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—MAPK1—melanoma	1.62e-05	6.34e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—melanoma	1.62e-05	6.33e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—melanoma	1.61e-05	6.31e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ERCC2—melanoma	1.61e-05	6.3e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK3—melanoma	1.61e-05	6.29e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CD—melanoma	1.61e-05	6.29e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB2—melanoma	1.6e-05	6.27e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—melanoma	1.6e-05	6.26e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1A—melanoma	1.6e-05	6.24e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTEN—melanoma	1.59e-05	6.23e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—melanoma	1.59e-05	6.21e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NFKB1—melanoma	1.58e-05	6.2e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CB—melanoma	1.58e-05	6.19e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAP2K1—melanoma	1.57e-05	6.15e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNA11—melanoma	1.57e-05	6.14e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—melanoma	1.57e-05	6.12e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CD—melanoma	1.56e-05	6.11e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—melanoma	1.55e-05	6.07e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	1.55e-05	6.05e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—FASN—melanoma	1.54e-05	6.01e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK1—melanoma	1.53e-05	5.99e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—melanoma	1.53e-05	5.99e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—melanoma	1.53e-05	5.98e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—melanoma	1.52e-05	5.95e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CA—melanoma	1.52e-05	5.93e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC5A5—melanoma	1.51e-05	5.91e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HRAS—melanoma	1.51e-05	5.91e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGF2—melanoma	1.5e-05	5.85e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1B—melanoma	1.49e-05	5.81e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—melanoma	1.47e-05	5.74e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—melanoma	1.47e-05	5.73e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNAQ—melanoma	1.46e-05	5.71e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CD44—melanoma	1.46e-05	5.71e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—melanoma	1.46e-05	5.69e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—melanoma	1.45e-05	5.68e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—melanoma	1.45e-05	5.66e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—melanoma	1.45e-05	5.65e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—melanoma	1.44e-05	5.62e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—melanoma	1.42e-05	5.57e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NRAS—melanoma	1.42e-05	5.55e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—melanoma	1.42e-05	5.54e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTEN—melanoma	1.41e-05	5.51e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CA—melanoma	1.41e-05	5.5e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CTNNB1—melanoma	1.4e-05	5.49e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HRAS—melanoma	1.4e-05	5.48e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CB—melanoma	1.4e-05	5.48e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1B1—melanoma	1.4e-05	5.48e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MDM2—melanoma	1.4e-05	5.48e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—melanoma	1.39e-05	5.43e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB2—melanoma	1.38e-05	5.4e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—melanoma	1.38e-05	5.38e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1A—melanoma	1.37e-05	5.36e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTEN—melanoma	1.37e-05	5.35e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CB—melanoma	1.36e-05	5.33e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NFKB1—melanoma	1.36e-05	5.32e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK3—melanoma	1.36e-05	5.32e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—melanoma	1.34e-05	5.25e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—melanoma	1.33e-05	5.22e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CA—melanoma	1.33e-05	5.2e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—melanoma	1.32e-05	5.17e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—melanoma	1.31e-05	5.12e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HRAS—melanoma	1.3e-05	5.09e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK1—melanoma	1.29e-05	5.06e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—melanoma	1.29e-05	5.06e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—melanoma	1.29e-05	5.03e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1B—melanoma	1.28e-05	5e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CG—melanoma	1.27e-05	4.97e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—melanoma	1.26e-05	4.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—melanoma	1.25e-05	4.9e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—melanoma	1.25e-05	4.89e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—melanoma	1.24e-05	4.87e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—melanoma	1.24e-05	4.84e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—melanoma	1.24e-05	4.83e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HRAS—melanoma	1.23e-05	4.81e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARG—melanoma	1.23e-05	4.8e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—melanoma	1.22e-05	4.78e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—melanoma	1.22e-05	4.78e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NRAS—melanoma	1.22e-05	4.77e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—melanoma	1.22e-05	4.77e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTEN—melanoma	1.21e-05	4.74e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CTNNB1—melanoma	1.21e-05	4.72e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—melanoma	1.18e-05	4.63e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1A—melanoma	1.18e-05	4.61e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTEN—melanoma	1.18e-05	4.6e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—melanoma	1.18e-05	4.6e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NFKB1—melanoma	1.17e-05	4.58e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK3—melanoma	1.17e-05	4.57e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCB1—melanoma	1.15e-05	4.51e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—melanoma	1.15e-05	4.49e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—melanoma	1.14e-05	4.44e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CA—melanoma	1.12e-05	4.39e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CD—melanoma	1.12e-05	4.37e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK1—melanoma	1.11e-05	4.35e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—melanoma	1.11e-05	4.35e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—melanoma	1.1e-05	4.31e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—melanoma	1.09e-05	4.25e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—melanoma	1.09e-05	4.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—melanoma	1.06e-05	4.16e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PRKCA—melanoma	1.06e-05	4.15e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—melanoma	1.05e-05	4.12e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ERCC2—melanoma	1.05e-05	4.12e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NRAS—melanoma	1.05e-05	4.11e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—melanoma	1.05e-05	4.11e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HRAS—melanoma	1.04e-05	4.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK3—melanoma	1.01e-05	3.93e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—melanoma	9.95e-06	3.89e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CA—melanoma	9.93e-06	3.88e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—melanoma	9.78e-06	3.83e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CB—melanoma	9.74e-06	3.81e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—melanoma	9.65e-06	3.77e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CA—melanoma	9.65e-06	3.77e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK1—melanoma	9.57e-06	3.74e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—melanoma	9.57e-06	3.74e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—melanoma	9.33e-06	3.65e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—melanoma	9.18e-06	3.59e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—melanoma	9.04e-06	3.53e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HRAS—melanoma	8.92e-06	3.49e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CA—melanoma	8.54e-06	3.34e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—melanoma	8.54e-06	3.34e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTEN—melanoma	8.42e-06	3.29e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CG—melanoma	8.31e-06	3.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CA—melanoma	8.31e-06	3.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—melanoma	8.11e-06	3.17e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—melanoma	8.03e-06	3.14e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARG—melanoma	8.02e-06	3.14e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—melanoma	7.88e-06	3.08e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HRAS—melanoma	7.68e-06	3e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—melanoma	7.35e-06	2.88e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CD—melanoma	7.31e-06	2.86e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—melanoma	7.21e-06	2.82e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—melanoma	6.98e-06	2.73e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—melanoma	6.78e-06	2.65e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CB—melanoma	6.37e-06	2.49e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—melanoma	6.31e-06	2.47e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CA—melanoma	5.94e-06	2.32e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTEN—melanoma	5.5e-06	2.15e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—melanoma	4.85e-06	1.9e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CA—melanoma	3.88e-06	1.52e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—melanoma	3.17e-06	1.24e-05	CbGpPWpGaD
